GYN (part 3)-Exam 2 Flashcards
Papanicolaou test – “Pap Smear”
* Routine screening for what?
* May also screen for what?
* When should you should you start screenign?
* What should be biopsied?
- Routine screening for cervical cancer, or cell changes known to lead to cancer
- May also screen for HPV
- Should start screening at age 21, even if sexually active earlier.
- ALL visible abnormal cervical lesions should be biopsied
Under notes
What is the timeline for paps?
Anyone with a cervix between the ages of 21 and 30 should get a Pap smear at least once every three years.Between the ages of 30 and 65, you should have one every five years.
How do you do the brush at the cervix?
Brush is the best at he squamocolumnar junction.
Where does 90% of squamous cervical intraepithelial neoplasia (CIN) occurs?
within the transformation
* This is why it is so important to get cells from the squamous epithelium (exocervix) and the columnar epithelium (endocervix).
She said FYI
Cervical Intraepithelial Neoplasia (CIN)
* Hormonal influence of puberty + changes in vaginal pH causes what?
causes squamous margin to encroach on the single-layer, mucous secreting epithelium, creating an area of metaplasia - “transformation zone”
Cervical Intraepithelial Neoplasia (CIN): HPV types
* What are the high risk HPV cancer related types
* HPV types associated with genital warts?
Human papillomavirus (HPV) types.
* High Risk HPV-cancer related types: 16 and 18 (70%), 31, 33 and 45
* HPV types associated with genital warts: 6 & 11 (90%) (condyloma acuminata)
Cervical Intraepithelial Neoplasia (CIN)
* What are the classification?
Describes degree of abnormality
* CIN 1 = LSIL
* CIN 2, 3 = HSIL
U. S. Preventive Services Task Force Recommendation: PAP
* When do you do screenings? (average risk group)
- Women aged 21-29 - screening with cytology (pap smear or liquid based) every 3 years
- Women aged 30-65 - screening with cytology every 3 years + HPV testing every 5 years or with co-testing (both) q 5 years
U. S. Preventive Services Task Force Recommendation: PAP
* What is the screening timeline for high risk group?
ANY previous abnormal cytology screening or HIV or DES exposure in utero -> yearly screening
American Cancer Society Guidelines: pap+HPV
* Screening should begin when?
* What is the timeline?
* Who should stop cervical cancer screening?
- Screening should begin at age 25
- Women aged 25-65 should have HPV test q 5 years combined with PAP test or a PAP test alone q 3 years
- Women over 65 who have had regular screenings for past 10 years with no history of CIN2 or more serious diagnosis should stop cervical cancer screening
Cerival cancer
* What is the most primary initating event? What is it?
* What are other risk factors?(4)
HPV infection is the primary initiating event
* HPV a double stranded DNA virus infects epithelium near transformation zone.
* HPV 16 & 18 most frequently associated
Other risk factors: Multiple sex partners, first intercourse <18yo, smoking, STD and DES exposure
- Most women are infected with HPV, but most clear it.
- Some women keep a chronic infection, and it is thought there is a genetic predisposition associated
Screening for cervical cancer
* What test
* make take how long to progress?
* Primary prevention is what?
- Pap test
- May take years to progress from dysplasia to cancer
- Primary prevention is via HPV vaccines
Clinical Presentation: Cervical cancer
* What are the early stages and later stages?
Early stages are asymptomatic
Later stages:
* Post-intercourse bleeding
* Intermenstrual cycle bleeding
* Persistent yellow discharge
* Foul smelling discharge
* Heavy menstrual bleeding
* Pelvic/sacral pain
* Most common presentation of later stage cancer is a visible lesion on the cervix
cervix cancer
* how do you dx it?
- Most found during Pap test screening of asymptomatic women
- Colposcopy with biopsy
- MRI or PET-CT used for staging
cervix cancer
* What are all the different treatments? (5)
How do you do cryotherapy?
Cervix cancer
* How do you conization/cone biopsy?
Cervix cancer
* How do you do a loop Excisional Biopsy?
LSIL Management
HSIL Management
AGC Management
* What do you for Atypical endocervical cells, favor neoplastic ; or Atypical glandular cells, favor neoplastic ?
- Colposcopy
- Endocervical Bx
- Diagnositic excisional cervical procedure
AGC Management
* What do you do for adenocarcinoma in-situ?
- Colposcopy
- Endocervical Bx
- Diagnositic excisional cervical procedure
Atypical Glandular Cells Management
Cervical Dysplasia Summary:
* What do you do if pap result show ASCUS or LSIL/CIN I
⭐️TEST
Test for HPV
Repeat pap in 2-12 months
If the pap shows ASCUS/LSIL CIN I is present again then perform a colposcopy: use of a colposcope to visualize vulva, vagina and cervix with magnification to evaluate benign, premalignant and potentially malignant disease
The lesions will turn white when acetic acid is applied
* Higher grade will cause greater/more rapid absorption (Higher grade= more white and faster)
Cervical Dysplasia Summary:
* What do you do if pap result shows HSIL/CIN II or III
LEEP or colposcopy and biopsy
Cervical Dysplasia Summary:
* What do you do if pap result shows AGC?
AGC can indicate adenocarcinoma in situ
* Repeat pap with endocervical brush, and if confirmed:
* Endometrial bx and cone bx of cervix
Cervical cancer: Prognosis
* Dependent on what?
* What is the treatment?
* How is it preventable?
* Gardasil vaccination targets what HPV Strands?
⭐️TEST
What is this?
Vestibulitis
Vulvar Intraepithelial Neoplasia: VIN, usualy type
* Occurs in who? What are the risk factors?(3)
- Occurs in younger, premenopausal women
- Risk factors: HPV infection, cigarette smoking, immunodeficiency or immunosuppression
Vulvar Intraepithelial Neoplasia: VIN, usualy type
* What does basaloid subtype have?
* What is warty subtype?
- Basaloid subtype has a thickened epithelium with a relatively flat, smooth surface
- Warty (condylomatous) subtype is characterized by a surface that is undulating or spiking, giving it a condylomatous appearance
Vulvar Intraepithelial Neoplasia: VIN, differentiated type
* Comprises of how much?
* Typically occurs in who?
* Not often assoicated with what?
- Comprises less than 5 percent of VIN
- Typically occurs in postmenopausal women
- Not often associated with HPV infection
Vulvar Intraepithelial Neoplasia
* What are the clinical manifestations?
- Pruritis
- Visible lesions
- Palpable abnormality
- Perineal pain or burning
- Dysuria
- 50% asymptomatic
Vulvar Intraepithelial Neoplasia
* What is for definitive dx?
- Tissue biopsy for definitive diagnosis; biopsy sites are identified by physical examination and colposcopy